ICON plc - Ordinary Shares (NQ:ICLR)

162.05 +0.20 (+0.12%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

ICON PLC (NASDAQ: ICLR) INVESTOR ALERT: Investors With Large Losses in ICON plc Should Contact Bernstein Liebhard LLP To Discuss Their Rights

February 11, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders to Contact the Firm for Information About Their Rights

February 11, 2025

From Rosen Law Firm

Via Business Wire

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

January 30, 2025

From ICON plc

Via Business Wire

NASDAQ:ICLR is an undervalued gem with solid fundamentals. ↗

January 27, 2025

When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,100 Today ↗

October 28, 2024

Via Benzinga

Spotlight on Icon: Analyzing the Surge in Options Activity ↗

October 24, 2024

Via Benzinga

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

January 29, 2025

From ICON plc

Via Business Wire

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗

January 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...

Via Benzinga

Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty ↗

January 14, 2025

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.

Via Benzinga

ICON Issues Financial Guidance for Full Year 2025

January 14, 2025

From ICON plc

Via Business Wire

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

January 08, 2025

From ICON plc

Via Business Wire

This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

January 07, 2025

Via Benzinga

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From ICON plc

Via Business Wire

NASDAQ:ICLR is an undervalued gem with solid fundamentals. ↗

December 27, 2024

For those who appreciate value investing, ICON PLC (NASDAQ:ICLR) is a compelling option with its solid fundamentals.

Via Chartmill

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

December 23, 2024

From ICON plc

Via Business Wire

ICON Announces Appointment of Chief Operating Officer

December 18, 2024

From ICON plc

Via Business Wire

13 Healthcare Sector Stocks With Healthy Valuation ↗

December 05, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...

Via Talk Markets

Topics Stocks Stocks / Equities

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

December 05, 2024

From ICON plc

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 27, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 26, 2024

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 25, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 15, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 15, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3 ↗

November 14, 2024

Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel...

Via Benzinga

Topics Regulatory Compliance

The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

November 14, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

ICON plc to Present at the Jefferies London Healthcare Conference

November 13, 2024

From ICON plc

Via Business Wire

Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? ↗

October 26, 2024

Ten large-cap stocks: ICON, Genuine Parts, Newmont, Tenet Healthcare, Universal Health, HCA Healthcare, TopBuild, Carlisle, Teradyne, Comfort Systems.

Via Benzinga

IBM Posts Weak Sales, Joins Garrett Motion, Beyond And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 24, 2024

Via Benzinga

This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

October 24, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2024

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.